Jaguar Health's board authorized the issuance of Series P non-convertible preferred stock with 300 shares designated. The filing establishes terms and conditions for this new preferred stock class, potentially indicating capital raising activity.
Jaguar Health's board authorized the issuance of Series P non-convertible preferred stock with 300 shares designated. The filing establishes terms and conditions for this new preferred stock class, potentially indicating capital raising activity.